GlobalRPh Renal Dosing Masterv6.6
GlobalRPh source record

Clindamycin

Cleocin

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (4)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

Professional source

UCSF - clindamycin

Product / population
Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Renal measure
Qualitative no-adjustment guidance for the specified adult regimens.

Dosing / renal protocol and limits

No routine kidney-function or hemodialysis reduction is recommended for these adult systemic regimens. Uncomplicated infection: 600 mg IV every 8 hours or 450 mg orally every 8 hours. Bone/joint infection: 600 mg orally every 8 hours. Necrotizing soft-tissue infection, group A streptococcal infection or pelvic inflammatory disease: 900 mg IV every 8 hours. Select the indication and route; the oral and IV choices are not additive.

Source revision: Revision date not stated in the reviewed page. | Retrieved: 2026-09-05. Retrieval date is not the revision date.

Source: https://idmp.ucsf.edu/content/clindamycin

Scope: Locally included source-specific summary. Regimen differences are not automatically resolved. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Preserved GlobalRPh source

Preserved original GlobalRPh source

Preserved historical content; not revalidated as current prescribing guidance.

Renal method: Read the measure and population stated in the original source sections.
Retrieved: 2026-09-05

Professional guidance

UCSF - clindamycin

Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.

Renal method: Qualitative no-adjustment guidance for the specified adult regimens.
Retrieved: 2026-09-05

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

Professional source

Stanford adult Clindamycin

Adult institutional dosing; not a manufacturer-label replacement.

Method: Not stated in selected source.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Choose two source checkboxes below.
Historical source content is not a current prescription. Original GlobalRPh recommendations are preserved, not automatically certified as current. Product-label and professional additions below are separately attributed. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Original GlobalRPh protocol

Clinical facts and comments transcribed into a structured reading format. This is not a byte-for-byte HTML archive. Original source: https://globalrph.com/renal/clindamycin/

Usual Dosing (Adults)

IV: 300 to 900 mg every 6 to 8 hours. Oral: 150 to 450 mg every 6 hours.

GRPH-clindamycin-01 · Source section: Usual Dosing (Adults)Renal section finder

Renal Dosing

No adjustments required.

GRPH-clindamycin-02 · Source section: Renal DosingRenal section finder

Hemodialysis

No adjustments required.

GRPH-clindamycin-03 · Source section: HemodialysisRenal section finder
Separate professional-source layer

University and professional protocols

Professional

Stanford adult Clindamycin

Open original reference

Open / share this exact local source

Stanford Antimicrobial Safety and Sustainability Program · Adult institutional dosing; not a manufacturer-label replacement.

Renal method: Not specified in this summary.
Source date: Antibiotic Subcommittee approved August 2026
Retrieved: 2026-09-05

Source-read local summary; source-specific recommendations are not automatically interchangeable.

Source-specific regimen

Adults: 600-900 mg IV every 8 hours or 150-450 mg orally every 6 hours. The table specifies no renal, HD or CRRT change.

clindamycin:stanford-clindamycin-1 · Source locator: PDF page 3, Clindamycin row

Source identity and provenance
Source
https://med.stanford.edu/content/dam/sm/bugsanddrugs/documents/antimicrobial-dosing-protocols/SHC-ABX-Dosing-Guide.pdf
Retrieved
2026-09-05
Source date/version
Antibiotic Subcommittee approved August 2026
Hash meaning
Locally authored source summary, not original SPL/XML/PDF bytes
Local summary SHA-256
72b3c311924676315bdce147ddc1c7e5ae04fb66a105381de66d4fb5e5b4f933
Professional

Nebraska Medicine: Clindamycin

Open original reference

Open / share this exact local source

UNMC / Nebraska Medicine · CRRT/PIRRT statement only; select the indication-specific baseline dose separately.

Renal method: Not specified in this summary.
Source date: Not established
Retrieved: 2026-09-05

Source-read local summary; source-specific recommendations are not automatically interchangeable.

Renal-replacement statement

Clindamycin is listed among agents not requiring adjustment specifically for CRRT/PIRRT.

clindamycin:unmc-crrt-statement-clindamycin-1 · Source locator: PDF page 2: no-adjustment list

Source identity and provenance
Source
https://www.unmc.edu/intmed/_documents/id/asp/final_crrt_pirrt_abxrecommendations_2023.pdf
Retrieved
2026-09-05
Hash meaning
Locally authored source summary, not original SPL/XML/PDF bytes
Local summary SHA-256
ab69796b91db541943556d01c2c939a9bfa7cbeb289de5bff194997c6701410a
Professional

UCSF - clindamycin

Open original reference

Open / share this exact local source

UCSF Infectious Diseases Management Program · Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.

Renal method: Qualitative no-adjustment guidance for the specified adult regimens.
Source date: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

No routine kidney-function or hemodialysis reduction is recommended for these adult systemic regimens. Uncomplicated infection: 600 mg IV every 8 hours or 450 mg orally every 8 hours. Bone/joint infection: 600 mg orally every 8 hours. Necrotizing soft-tissue infection, group A streptococcal infection or pelvic inflammatory disease: 900 mg IV every 8 hours. Select the indication and route; the oral and IV choices are not additive.

RDM30-020-clindamycin-1 · Source locator: UCSF - clindamycin; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://idmp.ucsf.edu/content/clindamycin
Retrieved
2026-09-05
Renal-function method
Qualitative no-adjustment guidance for the specified adult regimens.
Source date/version
Revision date not stated in the reviewed page.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
6c1758d19e7806500fca2698860061e69afda4365c0e2d8729cb3e992f822623

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 0 RX List, 3 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/renal/clindamycin/
Source retrieval
2026-09-05. This is not the source publication or label revision date.
Original source type
globalrph individual
Local text SHA-256
93aeb6cac678712fb474eaf72d258168ad0faa3e2aa3a737839c8fa7615a7cd6
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

The original individual GlobalRPh pages commonly cite NIH/NLM DailyMed and instruct readers to review the applicable package insert for updates. That historical reference is preserved as context; it is not counted as an independently retrieved current label.

Read the full coverage report